Cargando…

COVID-19 variants as moving targets and how to stop them by glycoengineered whole-virus vaccines

Detalles Bibliográficos
Autor principal:	Galili, Uri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346202/ https://www.ncbi.nlm.nih.gov/pubmed/34304693 http://dx.doi.org/10.1080/21505594.2021.1939924

Ejemplares similares

Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes
por: Galili, Uri
Publicado: (2020)

Marketing trials, marketing tricks — how to spot them and how to stop them
por: Matheson, Alastair
Publicado: (2017)

Direct quality control of glycoengineered erythropoietin variants
por: Čaval, Tomislav, et al.
Publicado: (2018)

Moving targets: COVID-19 vaccine efficacy against Omicron subvariants
por: da Silva, Maria Karolaynne, et al.
Publicado: (2022)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

The Applications of Metabolic Glycoengineering
por: Ying, Liwei, et al.
Publicado: (2022)

Septic shock resuscitation: what goals and how to achieve them?
por: Jakob, Stephan M
Publicado: (2009)

All bleeding stops: how we can help...
por: Riordan, William P, et al.
Publicado: (2010)

Stop stunting: Pakistan perspective on how this could be realized
por: Das, Jai K., et al.
Publicado: (2016)

Commentary: Perception is reality, but reality is how you make them feel
por: Theeuwen, Hailey A., et al.
Publicado: (2021)

How Mesp1 makes a move
por: Kelly, Robert G.
Publicado: (2016)

Genetic glycoengineering in mammalian cells
por: Narimatsu, Yoshiki, et al.
Publicado: (2021)

Strategies for Glycoengineering Therapeutic Proteins
por: Dammen-Brower, Kris, et al.
Publicado: (2022)

Moving vaccination beyond partisan politics
por: Hoffman, Beth L., et al.
Publicado: (2022)

How to Stop Cognitive Processes is as Important as How to Start Them. Commentary on Dipoppa et al.
por: Munk, Matthias H. J.
Publicado: (2016)

Historical perspectives on prevention paradox: When the population moves as a whole
por: Raza, Syed Ahsan, et al.
Publicado: (2018)

Knowing How to Stop: Ceasing Prescribing When the Medicine Is No Longer Required
por: Ostini, Remo, et al.
Publicado: (2012)

How to stop the virus
por: Hamzelou, Jessica
Publicado: (2020)

Can THEM6 targeting stop resistance to prostate cancer treatment?
por: Chattopadhyay, Mrittika, et al.
Publicado: (2022)

Motivational Interviewing: moving from why to how with autonomy support
por: Resnicow, Ken, et al.
Publicado: (2012)

Nutritional research is moving to a whole-diet approach, time for food policy
por: McKenzie, Briar L., et al.
Publicado: (2021)

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines
por: Price, Nancy L., et al.
Publicado: (2016)

Development of a novel glycoengineering platform for the rapid production of conjugate vaccines
por: Abouelhadid, Sherif, et al.
Publicado: (2023)

Cyclopropene derivatives of aminosugars for metabolic glycoengineering
por: Hassenrück, Jessica, et al.
Publicado: (2019)

They Will Never Forget How You Made Them Feel: Implementing Harm Reduction in the Perinatal Setting
por: Puccio, Joelle
Publicado: (2023)

Time to stop the use of ‘Wuhan virus’, ‘China virus’ or ‘Chinese virus’ across the scientific community
por: Su, Zhaohui, et al.
Publicado: (2020)

Inactivated enterovirus A71 vaccines and moving forward
por: Shimizu, Hiroyuki
Publicado: (2021)

How S4 Segments Move Charge. Let Me Count the Ways
por: Horn, Richard
Publicado: (2004)

Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?
por: McLornan, Donal, et al.
Publicado: (2013)

How to stop vaccine hesitancy
por: Vaughan, Adam
Publicado: (2020)

Progress on the research and development of inactivated EV71 whole-virus vaccines
por: Liang, Zheng-Lun, et al.
Publicado: (2013)

Moving from rhetoric to action: how Africa can use scientific evidence to halt the COVID-19 pandemic
por: Olu, Olushayo Oluseun, et al.
Publicado: (2020)

COVID-19 vaccines and vaccination: how prepared is Africa?
por: Ariyo, Olumuyiwa Elijah, et al.
Publicado: (2021)

Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
por: Passmore, Ian J., et al.
Publicado: (2019)

Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice
por: Li, Xin, et al.
Publicado: (2021)

Moving miRNAs to therapeutic targets in colorectal cancer
por: McGregor, Mark, et al.
Publicado: (2019)

Cruising along Microtubule Highways: How Membranes Move through the Secretory Pathway
por: Bloom, George S., et al.
Publicado: (1998)

Disparities, variations, inequalities or inequities: whatever you call them, we need data to monitor them
por: Mindell, Jennifer S.
Publicado: (2019)

The STOP the Bleeding Campaign
por: Rossaint, Rolf, et al.
Publicado: (2013)

The conversation that never stopped
por: Sfard, Anna
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_11qjq17sjcn9c71gjhtefnmnrh